Inactive Instrument
Pressure BioSciences, Inc. Stock Nasdaq
Stocks
US74112E1091
Advanced Medical Equipment & Technology
OTC Markets Traded|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| Market Cap | 143K 125K 118K 107K 201K 13.73M 202K 1.41M 544K 6.98M 539K 527K 22.34M | P/E 2022 |
-0.81x | P/E 2023 | -0.22x |
|---|---|---|---|---|---|
| Enterprise Value | 22.95M 19.99M 18.92M 17.19M 32.11M 2.2B 32.27M 225M 87.13M 1.12B 86.21M 84.29M 3.58B | EV / Sales 2022 |
21.1x | EV / Sales 2023 | 15.5x |
| Free-Float |
99.27% | Yield 2022 * |
-
| Yield 2023 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 75 | 16/04/2004 | |
| Chief Tech/Sci/R&D Officer | 61 | 03/04/2006 | |
Edmund Ting
CTO | Chief Tech/Sci/R&D Officer | 72 | 24/04/2006 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 75 | 01/01/1992 | |
Jeffrey Peterson
CHM | Chairman | 70 | 08/08/2012 |
Michael Urdea
BRD | Director/Board Member | 73 | 08/02/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.53% | +9.14% | +39.29% | +27.70% | 240B | |
| +1.99% | +5.97% | +10.14% | -16.75% | 146B | |
| +0.33% | +6.40% | -11.56% | +29.78% | 135B | |
| -0.82% | +1.04% | -55.79% | -17.67% | 63.64B | |
| +0.16% | 0.00% | -18.71% | -16.71% | 49.27B | |
| -1.15% | +1.71% | +17.35% | +20.56% | 51.46B | |
| +1.72% | +9.24% | +23.37% | +34.88% | 43.33B | |
| +2.65% | +6.99% | +41.50% | +55.81% | 41.13B | |
| +7.10% | +21.82% | +143.07% | +67.76% | 34.57B | |
| Average | +1.45% | +4.95% | +20.96% | +20.59% | 89.41B | |
| Weighted average by Cap. | +1.20% | +6.30% | +16.69% | +16.74% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 1.73M 1.51M 1.43M 1.3M 2.42M 166M 2.43M 16.98M 6.57M 84.17M 6.5M 6.35M 269M | 1.98M 1.72M 1.63M 1.48M 2.77M 189M 2.78M 19.42M 7.51M 96.26M 7.43M 7.26M 308M |
| Net income | -16.08M -14M -13.25M -12.04M -22.49M -1.54B -22.61M -158M -61.04M -782M -60.39M -59.05M -2.5B | -29.31M -25.53M -24.16M -21.96M -41.02M -2.81B -41.22M -288M -111M -1.43B -110M -108M -4.57B |
| Net Debt | 20.53M 17.88M 16.92M 15.37M 28.72M 1.97B 28.86M 202M 77.93M 999M 77.11M 75.39M 3.2B | 22.8M 19.86M 18.8M 17.08M 31.91M 2.18B 32.07M 224M 86.58M 1.11B 85.67M 83.76M 3.55B |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
